SGCB and type 1 diabetes mellitus: Cinaciguat, an sGC activator, improved the glomerular filtration rate and attenuated renal fibrosis in streptozotocin-induced Type 1 diabetic mice with and without endothelial nitric oxide synthase (eNOS) knockout [7].